116 related articles for article (PubMed ID: 8993577)
1. Peroxisome proliferators: species differences in response of primary hepatocyte cultures.
Elcombe CR; Bell DR; Elias E; Hasmall SC; Plant NJ
Ann N Y Acad Sci; 1996 Dec; 804():628-35. PubMed ID: 8993577
[No Abstract] [Full Text] [Related]
2. The peroxisome proliferators are hepatocyte mitogens in chemically-defined media: glucocorticoid-induced PPAR alpha is linked to peroxisome proliferator mitogenesis.
Plant NJ; Horley NJ; Savory RL; Elcombe CR; Gray TJ; Bell DR
Carcinogenesis; 1998 May; 19(5):925-31. PubMed ID: 9635884
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis of non-responsiveness to peroxisome proliferators: the guinea-pig PPARalpha is functional and mediates peroxisome proliferator-induced hypolipidaemia.
Bell AR; Savory R; Horley NJ; Choudhury AI; Dickins M; Gray TJ; Salter AM; Bell DR
Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):689-93. PubMed ID: 9620871
[TBL] [Abstract][Full Text] [Related]
4. Hepatic peroxisome proliferators induce morphologic transformation of Syrian hamster embryo cells, but not peroxisomal beta oxidation.
Sanner T; Mikalsen SO; Rivedal E
Prog Clin Biol Res; 1991; 369():77-89. PubMed ID: 1946545
[No Abstract] [Full Text] [Related]
5. Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs.
Reddy MK; Lalwani ND; Qureshi SA; Reddy JK
Hum Toxicol; 1982 Mar; 1(2):135-47. PubMed ID: 7173894
[TBL] [Abstract][Full Text] [Related]
6. Protein phosphorylation by peroxisome proliferators: species-specific stimulation of protein kinases and its role in PP-induced transcriptional activation.
Motojima K; Passilly P; Jannin B; Latruffe N
Ann N Y Acad Sci; 1996 Dec; 804():413-23. PubMed ID: 8993560
[No Abstract] [Full Text] [Related]
7. Pretreatment with peroxisome proliferators protects mice against some but not all hepatotoxins.
Nicholls-Grzemski FA; Burcham PC; Calder IC; Priestly BG
Ann N Y Acad Sci; 1996 Dec; 804():742-4. PubMed ID: 8993611
[No Abstract] [Full Text] [Related]
8. Peroxisome proliferators induce high levels of DNA synthesis in primary cultures of rat hepatocytes.
Bell DR; Plant NJ; Horley NJ; Elcombe CR
Ann N Y Acad Sci; 1996 Dec; 804():745-6. PubMed ID: 8993612
[No Abstract] [Full Text] [Related]
9. The coordinate regulation of DNA synthesis and suppression of apoptosis is differentially regulated by the liver growth agents, phenobarbital and methylclofenapate.
Plant NJ; Horley NJ; Dickins M; Hasmall S; Elcombe CR; Bell DR
Carcinogenesis; 1998 Sep; 19(9):1521-7. PubMed ID: 9771920
[TBL] [Abstract][Full Text] [Related]
10. 32P-postlabeling analysis of peroxisome proliferator-DNA adduct formation in rat liver in vivo and hepatocytes in vitro.
Gupta RC; Goel SK; Earley K; Singh B; Reddy JK
Carcinogenesis; 1985 Jun; 6(6):933-6. PubMed ID: 4006083
[TBL] [Abstract][Full Text] [Related]
11. Species differences in response to peroxisome proliferators correlate in vitro with induction of DNA synthesis rather than suppression of apoptosis.
James NH; Roberts RA
Carcinogenesis; 1996 Aug; 17(8):1623-32. PubMed ID: 8761418
[TBL] [Abstract][Full Text] [Related]
12. Hepatic catalase is not essential for the hypolipidemic action of peroxisome proliferators.
Reddy JK; Moody DE; Azarnoff DL; Rao MS
Proc Soc Exp Biol Med; 1977 Apr; 154(4):483-7. PubMed ID: 859854
[No Abstract] [Full Text] [Related]
13. Hepatic peroxisome proliferation: induction by two novel compounds structurally unrelated to clofibrate.
Reddy JK; Krishnakantha TP
Science; 1975 Nov; 190(4216):787-9. PubMed ID: 1198095
[TBL] [Abstract][Full Text] [Related]
14. Role of eicosanoid metabolism in carcinogenesis by peroxisome proliferators.
Glauert HP; Hong JT; Leung LK; Wilson MW
Ann N Y Acad Sci; 1996 Dec; 804():719-21. PubMed ID: 8993604
[No Abstract] [Full Text] [Related]
15. Acute hyperplasia and peroxisome proliferation induced by methylclofenapate: a species comparison and implications for liver carcinogenesis.
Styles JA; Kelly MD; Pritchard NR; Elcombe CR
Prog Clin Biol Res; 1990; 331():385-93. PubMed ID: 2315346
[No Abstract] [Full Text] [Related]
16. Microbody proliferation in liver induced by nafenopin, a new hypolipidemic drug: comparison with CPIB.
Reddy J; Svoboda D; Azarnoff D
Biochem Biophys Res Commun; 1973 May; 52(2):537-43. PubMed ID: 4711169
[No Abstract] [Full Text] [Related]
17. Induction of fatty acid binding protein by peroxisome proliferators in primary hepatocyte cultures and its relationship to the induction of peroxisomal beta-oxidation.
Brandes R; Kaikaus RM; Lysenko N; Ockner RK; Bass NM
Biochim Biophys Acta; 1990 Apr; 1034(1):53-61. PubMed ID: 2328261
[TBL] [Abstract][Full Text] [Related]
18. The effects of hypolipidemic peroxisome proliferators on the induction of sister chromatid exchanges.
Linnainmaa K
Basic Life Sci; 1984; 29 Pt B():965-74. PubMed ID: 6397193
[No Abstract] [Full Text] [Related]
19. Species differences in the hepatic response to a potent peroxisome proliferator.
Makowska JM; Bonner FW; Goldfarb PS; Gibson GG
Biochem Soc Trans; 1989 Dec; 17(6):1072-3. PubMed ID: 2628085
[No Abstract] [Full Text] [Related]
20. Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators.
Reddy JK; Lalwani ND; Reddy MK; Qureshi SA
Cancer Res; 1982 Jan; 42(1):259-66. PubMed ID: 7053853
[No Abstract] [Full Text] [Related]
[Next] [New Search]
